Feed/Investors/Forbion, through its Growth and Ventures strategies

Forbion, through its Growth and Ventures strategies

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-11-11

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$82.9M

across 1 round

LATEST ROUND

Funding round · $82.9M · 2026-11-11

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
VectorY Therapeutics A clinical-stage biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases	Funding round Verified against 1 of 9 sources	$82.9M	2026-11-11	[ PART ]